Source: Annual Congress 2001 - Inhaled corticosteroids
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. P. Kemp, A. S. Nayak, D. I. Bernstein, G. Rachelefsky, J. E. Harrison, K. B. Nolop (San Diego, Normal, Cincinnati, Los Angeles, Kenilworth, United States Of America). Efficacy of mometasone furoate in patients with mild-to-moderate asthma: lack of gender-specific effects. Eur Respir J 2001; 16: Suppl. 31, 687

Member's Comments

No comment yet.

Related content which might interest you: Clinical efficacy of once-daily mometasone furoate in children with persistent asthma switched from treatment with fluticasone propionate Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 Mometasone furoate is safe and effective for long-term use in patients with mild-to-moderate persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001 Efficacy and safety of combined mometasone furoate/formoterol 200/10μg in persistent asthmatics Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Administration of mometasone furoate once daily in the evening is as effective as mometasone furoate administered twice daily in improving lung function in patients with mild to moderate persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 33s Year: 2003 Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma Source: Eur Respir J 2014; 43: 773-782 Year: 2014 Efficacy and safety of ciclesonide compared with fluticasone propionate or budesonide in adolescent patients with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 458s Year: 2007 The pharmacokinetics of mometasone furoate administered by dry powder inhaler following single and multiple dosing in patients with mild-to-moderate persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 96s Year: 2001 Efficacy and safety of ciclesonide compared with fluticasone propionate in patients with moderate to severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006 Reduction in oral corticosteroid use with mometasone furoate DPI improves health-related quality of life in patients with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 395s Year: 2002 Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) compared with fluticasone propionate/salmeterol combination (FP/SAL) in adults and adolescents with persistent asthma Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Once-daily, evening administration of mometasone furoate dry powder inhaler improves pulmonary function in patients with mild to moderate persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 282s Year: 2003 Health-related quality of life effects of mometasone furoate dry-powder inhaler (MF DPI) in patients with mild to moderate persistent asthma previously using inhaled corticosteroids Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003 Efficacy and systemic effects of ciclesonide and fluticasone in asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 147s Year: 2001 Safety and efficacy of momethason furoate for usage in school children with mild to moderate persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 290s Year: 2003 Efficacy of the novel inhaled corticosteroid, fluticasone furoate (FF)/long-acting beta2-agonist, vilanterol (VI) combination in reducing COPD exacerbations Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012 Effects of mometasone furoate dry powder inhaler administered once-daily in the evening on symptom control in mild to moderate asthma Source: Eur Respir J 2003; 22: Suppl. 45, 282s Year: 2003 Additive effect of Zafirlukast in combination with Mometason furoate in treatment of Nasal polyps in patients with mild persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 372s Year: 2003 Efficiency of once-daily mometasone furoate in school children with seasonal allergic rhinitis and severe nasal congestion Source: Eur Respir J 2006; 28: Suppl. 50, 664s Year: 2006 Does health-related quality of life improve with QD and BID dosing of mometasone furoate dry-powder inhaler (MF DPI) in patients with mild to moderate persistent asthma previously using inhaled corticosteroids? Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003 Efficacy and safety of medium and high doses of mometasone furoate/formoterol combination treatment in subjects with severe asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010